Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load

被引:65
|
作者
Quarantelli, M
Ciarmiello, A
Morra, VB
Orefice, G
Larobina, M
Lanzillo, R
Schiavone, V
Salvatore, E
Alfano, B
Brunetti, A
机构
[1] CNR, Ist Biostruct & Bioimmagini, I-80131 Naples, Italy
[2] IRCCS, Fdn G Pascale, Dept Diagnost Imaging, Naples, Italy
[3] Univ Naples Federico II, Dept Neurog Sci, Naples, Italy
[4] Univ Naples Federico II, Dept Diagnost Imaging, Naples, Italy
关键词
relapsing-remitting multiple sclerosis; MRI; brain atrophy; segmentation; brain volume;
D O I
10.1016/S1053-8119(02)00018-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The aim of this study was to simultaneously measure in vivo volumes of gray matter (GM), normal white matter (WM), abnormal white matter (aWM), and cerebro-spinal fluid (CSF), and to assess their relationship in 50 patients with relapsing-remitting multiple sclerosis (RR-MS) (age range, 21-59; mean EDSS, 2.5; mean disease duration, 9.9 years), using an unsupervised multiparametric segmentation procedure applied to brain MR studies. Tissue volumes were normalized to total intracranial volume providing corresponding fractional volumes (fGM, faWM, fWM, and fCSF), subsequently corrected for aWM-related segmentation inaccuracies and adjusted to mean patients' age according to age-related changes measured in 54 normal volunteers (NV) (age range 16-70). In MS patients aWM was 23.8 +/- 29.8 ml (range 0.4-138.8). A significant decrease in fGM was present in MS patients as compared to NV (49.5 3.2% vs 53.3 +/- 2.1%; P < 0.0001), with a corresponding increase in fCSF (13.0 +/- 3.8% vs 9.1 +/- 2.4%; P < 0.0001). No difference could be detected between the two groups for fWM (37.5 +/- 2.6% vs 37.6 +/- 2.2%). faWM correlated inversely with fGM (R = -0.434, P < 0.001 at regression analysis), and directly with fCSF (R 0.473, P < 0.001), but not with fWM. There was a significant correlation between disease duration and EDSS, while no relationship was found between EDSS or disease duration and fractional volumes. Brain atrophy in RR-MS is mainly related to GM loss, which correlates with faWM. Both measures do not appear to significantly affect EDSS, which correlates to disease duration. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:360 / 366
页数:7
相关论文
共 50 条
  • [1] The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis
    Borges, Isabela T.
    Shea, Colin D.
    Ohayon, Joan
    Jones, Blake C.
    Stone, Roger D.
    Ostuni, John
    Shiee, Navid
    McFarland, Henry
    Bielekova, Bibiana
    Reich, Daniel S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (02) : 133 - 140
  • [2] Short-term brain atrophy changes in relapsing-remitting multiple sclerosis
    Zivadinov, R
    Bagnato, F
    Nasuelli, D
    Bastianello, S
    Bratina, A
    Locatelli, L
    Watts, K
    Finamore, L
    Grop, A
    Dwyer, M
    Catalan, M
    Clemenzi, A
    Millefiorini, E
    Bakshi, R
    Zorzon, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 223 (02) : 185 - 193
  • [3] Quantitative Determination of Regional Lesion Volume and Distribution in Children and Adults with Relapsing-Remitting Multiple Sclerosis
    Ghassemi, Rezwan
    Narayanan, Sridar
    Banwell, Brenda
    Sled, John G.
    Shroff, Manohar
    Arnold, Douglas L.
    PLOS ONE, 2014, 9 (02):
  • [4] Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis
    Klauser, Antoine M.
    Wiebenga, Oliver T.
    Eijlers, Anand J. C.
    Schoonheim, Menno M.
    Uitdehaag, Bernard M. J.
    Barkhof, Frederik
    Pouwels, Petra J. W.
    Geurts, Jeroen J. G.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (04) : 491 - 500
  • [5] Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients
    De Stefano, Nicola
    Tomic, Davorka
    Radue, Ernst-Wilhelm
    Sprenger, Till
    Meier, Daniela Piani
    Haring, Dieter
    Sormani, Maria Pia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 7 : 98 - 101
  • [6] MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-Ia
    Gasperini, C
    Paolillo, A
    Giugni, E
    Galgani, S
    Bagnato, F
    Mainero, C
    Onesti, E
    Bastianello, S
    Pozzilli, C
    MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (02) : 119 - 123
  • [7] Brain atrophy in clinically early relapsing-remitting multiple sclerosis
    Chard, DT
    Griffin, CM
    Parker, GJM
    Kapoor, R
    Thompson, AJ
    Miller, DH
    BRAIN, 2002, 125 : 327 - 337
  • [8] The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis
    Singhal, Tarun
    Tauhid, Shahamat
    Hurwitz, Shelley
    Neema, Mohit
    Bakshi, Rohit
    JOURNAL OF NEUROIMAGING, 2017, 27 (01) : 33 - 36
  • [9] Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab
    Costa Arpin, Eva
    Garcia Sobrino, Tania
    Dominguez Vivero, Clara
    Amigo Jorrin, Maria del Campo
    Rodriguez Regal, Ana
    Prieto Gonzalez, Jose
    Lema Bouzas, Manuela
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (01) : 5 - 12
  • [10] Spatiotemporal Distribution Pattern of White Matter Lesion Volumes and Their Association With Regional Grey Matter Volume Reductions in Relapsing-Remitting Multiple Sclerosis
    Bendfeldt, Kerstin
    Blumhagen, Jan Ole
    Egger, Hanspeter
    Loetscher, Patrick
    Denier, Niklaus
    Kuster, Pascal
    Traud, Stefan
    Mueller-Lenke, Nicole
    Naegelin, Yvonne
    Gass, Achim
    Hirsch, Jochen
    Kappos, Ludwig
    Nichols, Thomas E.
    Radue, Ernst-Wilhelm
    Borgwardt, Stefan J.
    HUMAN BRAIN MAPPING, 2010, 31 (10) : 1542 - 1555